Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors
NCT03352531
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
BIOLOGICAL:
AK-105
Sponsor
Akesobio Australia Pty Ltd